Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 86SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.

In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms

Open access
Cankat, S., Demael, M. U., Swadling, L.·2023·Cellular & Molecular Immunology

Abstract

Members of the coronaviridae family are endemic to human populations and have caused several epidemics and pandemics in recent history. In this review, we will discuss the feasibility of and progress toward the ultimate goal of creating a pan-coronavirus vaccine that can protect against infection and disease by all members of the coronavirus family. We will detail the unmet clinical need associated with the continued transmission of SARS-CoV-2, MERS-CoV and the four seasonal coronaviruses (HCoV-OC43, NL63, HKU1 and 229E) in humans and the potential for future zoonotic coronaviruses. We will highlight how first-generation SARS-CoV-2 vaccines and natural history studies have greatly increased our understanding of effective antiviral immunity to coronaviruses and have informed next-generation vaccine design. We will then consider the ideal properties of a pan-coronavirus vaccine and propose a blueprint for the type of immunity that may offer cross-protection. Finally, we will describe a subset of the diverse technologies and novel approaches being pursued with the goal of developing broadly or universally protective vaccines for coronaviruses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41423-023-01116-8

Cites

200 of 200 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Phylogeny of coronaviruses and the breadth of protection afforded by different types of vaccines. Updated vaccines containing Omicron BA.1 or later sequences of spike have been designed to offer improved single-variant protection against currently circulating strains of SARS-CoV-2 compared with licensed vaccines. Next-generation vaccines are being designed to offer broader protection, for instance, pan-variant vaccines that could target all variants of the single viral species, SARS-CoV-2; pan-subgenus vaccines that target all members of the subgenus sarbecoviruses (including also SARS-CoV-1); pan-genus vaccines that include all members of the genus β-coronavirus (further including MERS-CoV, HCoV HKU1 and OC43); pan-subfamily vaccines that target all Orthocoronavirinae (also including alpha-coronaviruses HCoV NL63 and 229E); and pan-coronavirus vaccines that target all species within the Coronaviridae family. Created with BioRender.com
Fig. 1 Phylogeny of coronaviruses and the breadth of protection afforded by different types of vaccines. Updated vaccines containing Omicron BA.1 or later sequences of spike have been designed to offer improved single-variant protection against currently circulating strains of SARS-CoV-2 compared with licensed vaccines. Next-generation vaccines are being designed to offer broader protection, for instance, pan-variant vaccines that could target all variants of the single viral species, SARS-CoV-2; pan-subgenus vaccines that target all members of the subgenus sarbecoviruses (including also SARS-CoV-1); pan-genus vaccines that include all members of the genus β-coronavirus (further including MERS-CoV, HCoV HKU1 and OC43); pan-subfamily vaccines that target all Orthocoronavirinae (also including alpha-coronaviruses HCoV NL63 and 229E); and pan-coronavirus vaccines that target all species within the Coronaviridae family. Created with BioRender.comCC BY · PubMed Central
Fig. 2 Graphic summary of next-generation approaches for broadly targeted and pan-coronavirus vaccines, including nanoparticle delivery; the use of mosaic antigens or serial vaccination to educate the immune system with multiple versions of a given viral protein; the use of novel regions of the virus, in particular conserved regions outside of spike; and finally, consensus sequence design or computational antigen design, to select the antigenic sequence that induces the most broadly reactive immunity. NP nucleoprotein, NSP non-structural protein, ORF open reading frame, RBD receptor binding domain, RTC replication-transcription complex. Created with BioRender.com
Fig. 2 Graphic summary of next-generation approaches for broadly targeted and pan-coronavirus vaccines, including nanoparticle delivery; the use of mosaic antigens or serial vaccination to educate the immune system with multiple versions of a given viral protein; the use of novel regions of the virus, in particular conserved regions outside of spike; and finally, consensus sequence design or computational antigen design, to select the antigenic sequence that induces the most broadly reactive immunity. NP nucleoprotein, NSP non-structural protein, ORF open reading frame, RBD receptor binding domain, RTC replication-transcription complex. Created with BioRender.comCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 182 references

Cited by

See all 86

Metadata

Authors
Cankat, S., Demael, M. U., & Swadling, L.
Affiliations
University College London (GB)
Corresponding author
Swadling, L.
Venue
Cellular & Molecular Immunology
Published
2023-12-26
Volume
21
Issue
2
Pages
103-118
ISSN
  • 1672-7681 (ISSN-L)
  • 2042-0226
OpenAlex
W4390236634
Cited by
84
References
182
Citations by year
2026: 27 · 2025: 35 · 2024: 22
FWCI
3.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion, cc-by)
Funders
  • RCUK | Medical Research Council (MR/X502984/1, MR/W006774/1)
  • RCUK | Biotechnology and Biological Sciences Research Council (BB/T008709/1)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
pan-coronavirus vaccine, universal coronavirus vaccine, SARS-CoV-2, MERS-CoV, seasonal coronaviruses, zoonotic coronaviruses, cross-protection, antiviral immunity, vaccine design, COVID-19 vaccines
MeSH terms
SARS-CoV-2, COVID-19 Vaccines, Humans, Vaccination, Coronavirus OC43, Human, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms. https://app.cochat.ai/papers/10.1038/s41423-023-01116-8
The paper
Cankat, S., Demael, M. U., & Swadling, L. (2023). In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-023-01116-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.